Alesco Surgipharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.89 Cr
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 15.00 Cr
- Revenue Growth %
- Profit Growth -285.79%
- Ebitda -285.79%
- Net Worth -11.93%
- Total Assets 18.42%
About Alesco Surgipharma
Alesco Surgipharma Private Limited (ASPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 02 September 2021 (Three years and five months 21 days old ). Its registered office is in Bhopal, Madhya Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.89 Cr.
The company currently has active open charges totaling ₹15.00 Cr.
Manoj Modi and Ishita Modi serve as directors at the Company.
Company Details
- Location
Bhopal, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33112MP2021PTC057325
- Company No.
057325
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Sep 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Alesco Surgipharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ishita Modi  | Director | 10-Apr-2024 | Current |
| Manoj Modi | Director | 04-Sep-2021 | Current |
Financial Performance of Alesco Surgipharma.
Alesco Surgipharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 285.79% decrease in profit. The company's net worth observed a substantial decline by a decrease of 11.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alesco Surgipharma?
In 2023, Alesco Surgipharma had a public holding of 60.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Orient Kagaz Converters Private Limited.Manoj Modi is a mutual person
Noble Corrugators Pvt LtdManoj Modi is a mutual person
- Nexcity Solutions Private Limited
Manoj Modi is a mutual person
Charges (Loans)
₹15.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 15.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Nov 2023 | Hdfc Bank Limited | ₹15.00 Cr | Open |
How Many Employees Work at Alesco Surgipharma?
Alesco Surgipharma has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alesco Surgipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alesco Surgipharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
